Truist raised its price target for Pediatrix Medical to $31, up from $28.

Oct 30, 2026, 7:57 AM ETOpinionRead the original at marketscreener.com

Neutral

Truist raised its target price but kept its Hold rating. With no new business results in the story, the mixed analyst view does not change Pediatrix's outlook.

MD · Pediatrix Medical Group, Inc.

AI read · Neutral

The AI's read

The higher target points to a better estimate, but keeping the same rating tempers that signal. The story gives no new business results, so it does not show that Pediatrix's business outlook has changed.

Get alerts for MD

Follow Pediatrix Medical Group, Inc. (MD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MD

Free on the App Store and Google Play, or on the web.